Oryzon Genomics to Present at the 18th Annual Rodman & Renshaw Global Investment Conference and at BioPharm America 2016
BARCELONA, SPAIN and CAMBRIDGE MA.
Oryzon Genomics (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today its CEO, Dr. Carlos Buesa, will present a corporate overview at the 18TH Annual Rodman and Renshaw Global investment Conference. The conference will take place on September 11-13, 2016, at the Palace Hotel in New York City. Dr. Buesa is scheduled to present on Tuesday, September 13th at 2:35 pm ET.
Dr. Buesa will also present a corporate overview at the 9th Annual International Partnering Conference BioPharm America-2016. The event will take place on September 13-15 in Boston, at the Marriott Copley Place Hotel. Dr. Buesa is scheduled to present on September 14th in the afternoon CNS track starting at 1.30 pm ET.